Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalGranulocytesStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsHematopoietic Stem CellsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceHematopoiesisCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsRecombinant ProteinsSurvival RateWhole-Body IrradiationInfectionTime FactorsSurvival AnalysisLymphoma, T-CellDoxorubicinPlatelet CountHistocompatibilityPOEMS SyndromePrednisoneCarboplatinHistocompatibility TestingLeukemia, Myeloid, AcuteImmunosuppressive AgentsDexamethasoneTransplantation, IsogeneicNeutropeniaReceptors, Granulocyte Colony-Stimulating FactorVidarabineLeukocyte CountLeukemiaBlood Cell CountBone MarrowFollow-Up StudiesBlood CellsAntineoplastic AgentsBone Marrow PurgingLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesGranulocyte-Macrophage Colony-Stimulating FactorBone Marrow CellsMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousColony-Forming Units AssayLiver TransplantationLymphocyte DepletionT-LymphocytesLeukocytes, MononuclearCells, CulturedHematologic DiseasesOpportunistic InfectionsHistiocytosis, Non-Langerhans-CellLivedo ReticularisBlood Donors